Applied Spectral Imaging and KromaTiD Announce Strategic Commercial Partnership

Applied Spectral Imaging (ASI) and KromaTiD, Inc. announced that they have entered into a strategic commercial partnership granting ASI worldwide rights to market KromaTiD’s proprietary Pinpoint FISH™ (PPF) probes and assay services.

PPF is used by researchers around the world to directly analyze unique and small genomic targets in tissues, microarrays, and dissociated cells. 

“ASI’s imaging and analysis platform GenASIs will provide automation, advanced algorithms and image analysis capabilities to realize the full potential of the PPF technology” said Limor Shiposh, Chief Executive Officer of ASI. “ASI is excited to partner with KromaTiD and complete the existing offering with a unique set of high-quality probes”, Mrs. Shiposh added.

The combined availability of the ASI and KromaTiD technology platforms will benefit clinical laboratories, companies and research institutions, enhancing their capabilities to perform comprehensive genomic structural measurements and improve diagnostic accuracy.

Click to read the Official Press Release

Want to Learn More?
Learn More